In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
September 26th, 2005 | 22 | Yes |
Popular Name: LS-14255 LS-14255
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.34 | -0.53 | -51.34 | 2 | 4 | 1 | 46 | 294.378 | 4 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
TOP1-1-E | DNA Topoisomerase I (cluster #1 Of 1), Eukaryotic | Eukaryotes | 71 | 0.45 | Functional ≤ 10μM |
TOP2A-1-E | DNA Topoisomerase II Alpha (cluster #1 Of 1), Eukaryotic | Eukaryotes | 71 | 0.45 | Functional ≤ 10μM |
TOP2B-1-E | DNA Topoisomerase II Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 71 | 0.45 | Functional ≤ 10μM |
Z80017-2-O | A2780cisR (Cisplatin-resistant Ovarian Carcinoma Cells) (cluster #2 Of 2), Other | Other | 570 | 0.40 | Functional ≤ 10μM |
Z80125-1-O | DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other | Other | 2300 | 0.36 | Functional ≤ 10μM |
Z80166-1-O | HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other | Other | 990 | 0.38 | Functional ≤ 10μM |
Z80193-2-O | L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other | Other | 98 | 0.45 | Functional ≤ 10μM |
Z80224-5-O | MCF7 (Breast Carcinoma Cells) (cluster #5 Of 14), Other | Other | 3800 | 0.34 | Functional ≤ 10μM |
Z80362-1-O | P388 (Lymphoma Cells) (cluster #1 Of 8), Other | Other | 98 | 0.45 | Functional ≤ 10μM |
Z80493-3-O | SK-OV-3 (Ovarian Carcinoma Cells) (cluster #3 Of 6), Other | Other | 980 | 0.38 | Functional ≤ 10μM |
Z80768-1-O | CH1 (Ovarian Carcinoma Cells) (cluster #1 Of 1), Other | Other | 530 | 0.40 | Functional ≤ 10μM |
Z81034-6-O | A2780 (Ovarian Carcinoma Cells) (cluster #6 Of 10), Other | Other | 510 | 0.40 | Functional ≤ 10μM |
Z81072-6-O | Jurkat (Acute Leukemic T-cells) (cluster #6 Of 10), Other | Other | 580 | 0.40 | Functional ≤ 10μM |
Z81160-1-O | Lewis Lung Carcinoma Cell Line (cluster #1 Of 1), Other | Other | 190 | 0.43 | Functional ≤ 10μM |
Z81167-1-O | LLTC Cell Line (cluster #1 Of 1), Other | Other | 189 | 0.43 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
Z81034 | Z81034 | A2780 (Ovarian Carcinoma Cells) | 510 | 0.40 | Functional ≤ 10μM |
Z80017 | Z80017 | A2780cisR (Cisplatin-resistant Ovarian Carcinoma Cells) | 570 | 0.40 | Functional ≤ 10μM |
Z80768 | Z80768 | CH1 (Ovarian Carcinoma Cells) | 480 | 0.40 | Functional ≤ 10μM |
TOP1_MOUSE | Q04750 | DNA Topoisomerase I, Mouse | 190 | 0.43 | Functional ≤ 10μM |
TOP1_HUMAN | P11387 | DNA Topoisomerase I, Human | 580 | 0.40 | Functional ≤ 10μM |
TOP2A_MOUSE | Q01320 | DNA Topoisomerase II Alpha, Mouse | 190 | 0.43 | Functional ≤ 10μM |
TOP2A_HUMAN | P11388 | DNA Topoisomerase II Alpha, Human | 580 | 0.40 | Functional ≤ 10μM |
TOP2B_MOUSE | Q64511 | DNA Topoisomerase II Beta, Mouse | 190 | 0.43 | Functional ≤ 10μM |
TOP2B_HUMAN | Q02880 | DNA Topoisomerase II Beta, Human | 580 | 0.40 | Functional ≤ 10μM |
Z80125 | Z80125 | DU-145 (Prostate Carcinoma) | 2300 | 0.36 | Functional ≤ 10μM |
Z80166 | Z80166 | HT-29 (Colon Adenocarcinoma Cells) | 990 | 0.38 | Functional ≤ 10μM |
Z81072 | Z81072 | Jurkat (Acute Leukemic T-cells) | 300 | 0.42 | Functional ≤ 10μM |
Z80193 | Z80193 | L1210 (Lymphocytic Leukemia Cells) | 105 | 0.44 | Functional ≤ 10μM |
Z81160 | Z81160 | Lewis Lung Carcinoma Cell Line | 189 | 0.43 | Functional ≤ 10μM |
Z81167 | Z81167 | LLTC Cell Line | 189 | 0.43 | Functional ≤ 10μM |
Z80224 | Z80224 | MCF7 (Breast Carcinoma Cells) | 3800 | 0.34 | Functional ≤ 10μM |
Z80362 | Z80362 | P388 (Lymphoma Cells) | 110 | 0.44 | Functional ≤ 10μM |
Z80493 | Z80493 | SK-OV-3 (Ovarian Carcinoma Cells) | 2400 | 0.36 | Functional ≤ 10μM |
Description | Species |
---|---|
G0 and Early G1 |